Ziextenzo Injection
Product Images NDC 61314-866

14 FDA label images from Sandoz Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Ziextenzo (NDC 61314-866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ifu-fig-a (Zkex Image 01)

Ifu-fig-a (Zkex Image 01)
An instructional diagram of a prefilled syringe showing labeled parts including needle cap, needle guard, syringe barrel with viewing window, plunger stopper, finger grips, plunger, plunger head, and needle guard wings. The syringe barrel displays space for the label and expiration date.*
FDA Label Image

Ifu-fig-f (Zkex Image 03)

Ifu-fig-f (Zkex Image 03)
An illustration showing recommended subcutaneous injection sites on a human body, highlighting the stomach area and thigh. The diagram marks these areas on the front of the body for guidance on injection placement.*
FDA Label Image

Carton Label Clean

Carton Label Clean
Packaging label for ZIEXTENZO 6 mg/0.6 mL injection, containing pegfilgrastim-bmez, a subcutaneous human prescription drug by Sandoz Inc. The label advises single-dose prefilled syringe use with a needle guard, contains the NDC 61314-866-01, and includes storage and usage instructions emphasizing refrigeration and protection from light.*
FDA Label Image

Ifu-fig-c (Export 00)

Ifu-fig-c (Export 00)
An instructional diagram showing four components used in medication administration: a wipe, a cotton ball, a sharps disposal container labeled 'SHARPS' with a biohazard symbol, and an adhesive bandage.*
FDA Label Image

Ifu-fig-b (Image 01)

Ifu-fig-b (Image 01)
An instructional diagram of a subcutaneous injection device for ZIEXTENZO (pegfilgrastim-bmez) showing the internal mechanism and design components, illustrating how the injection is delivered through a spring-loaded system.*
FDA Label Image

Ifu-fig-d (Image 02)

Ifu-fig-d (Image 02)
An instructional illustration showing a hand holding a prefilled syringe labeled ZIEXTENZO (pegfilgrastim-bmez) injection, 6 mg/0.6 mL, demonstrating the proper method to remove the needle cap before subcutaneous injection.*
FDA Label Image

Ifu-fig-e (Image 03)

Ifu-fig-e (Image 03)
Illustration of a subcutaneous injection syringe with labeled parts including the needle cap, viewing window showing medicine, plunger stopper, and plunger. The diagram highlights components relevant to the administration of the injection.*
FDA Label Image

Ifu-fig-g (Image 05)

Ifu-fig-g (Image 05)
An instructional diagram showing preferred subcutaneous injection sites on the human body for ZIEXTENZO (pegfilgrastim-bmez) injection. The highlighted areas include the upper arm and buttocks as suitable injection locations.*
FDA Label Image

Ifu-fig-m (Image 11)

Ifu-fig-m (Image 11)
An instructional illustration showing a hand safely disposing a used prefilled syringe into a disposal container labeled 'SHARPS' with a biohazard symbol, promoting proper disposal of injection equipment.*
FDA Label Image

Ifu-fig-h (Image 13)

Ifu-fig-h (Image 13)
An instructional illustration showing hands removing the cap from a syringe needle, with an upward pointing arrow indicating the direction to pull the cap off. The syringe appears partially visible with the needle exposed after cap removal.*
FDA Label Image

Ifu-fig-i (Image 14)

Ifu-fig-i (Image 14)
An instructional illustration showing a hand administering a subcutaneous injection with an autoinjector device into the skin of a finger. The image includes an inset diagram indicating injection angles of 0°, 45°, and 90°.*
FDA Label Image

Ifu-fig-j (Image 15)

Ifu-fig-j (Image 15)
An instructional diagram showing a hand holding a syringe injection device. The image includes close-up circular insets highlighting specific parts or steps of the device, likely demonstrating how to properly handle or activate the injection mechanism for subcutaneous administration.*
FDA Label Image

Ifu-fig-k (Image 16)

Ifu-fig-k (Image 16)
An instructional illustration showing a hand holding and preparing to use a ZIEXTENZO (pegfilgrastim-bmez) injection device. The image depicts proper finger placement and indicates the direction to remove or activate a part of the prefilled subcutaneous injection.*
FDA Label Image

Ifu-fig-l (Image 17)

Ifu-fig-l (Image 17)
An instructional illustration showing hands holding a prefilled syringe, demonstrating the removal of the needle cap prior to subcutaneous injection for the drug ZIEXTENZO (pegfilgrastim-bmez) 6 mg/.6 mL injection by Sandoz Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.